Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke

A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 688 participants.

Also called NCT05105633

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2/3
Enrolled
  • 688 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05105633
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia, Brazil, France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05105633. Randomized; no masking; primary purpose treatment. Start 2021-11-29 (actual); primary completion 2028-05 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Extending the Time Window for Tenecteplase by Recanalization of Basilar Artery Occlusion in Posterior Circulation Stroke
Acronym
POST-ETERNAL
Condition
Basilar Artery Occlusion
Intervention (Drug)
Tenecteplase
Intervention (Drug)
Standard Care (which may include intravenous Alteplase)
Lead sponsor
University of Melbourne (class: other)

Record details

Record id
cardio:ct-nct05105633
Content hash
b308fb0a875b3d1b18dafb3ba31b2df4be38db370db721b8df713224b55ae055